Metro Inc. — the cost of waiting for grocery traffic to recover
Our maximum entry price is C$81.67 per share. Metro closed at C$97.58 on November 18, so the base model says wait. The five-year observed market-risk estimate raises entry to C$109.88 and changes the price decision to buy. TSX daily close, Nov 18
- Market close (CAD)
- $97.58
- Bear fair value (CAD/share)
- $47.83
Company details
- Base fair value (CAD/share)
- $94.27
- Bull fair value (CAD/share)
- $180.79
- Maximum entry price (CAD/share)
- $81.67
Only C$3.31 of the C$15.91 gap to entry comes from the DCF. The other C$12.60 comes from requiring a 9.5% annual return over five years. At the close the retained model earns 5.67%. A buyer could still meet our hurdle if diluted earnings grow 8% annually and Metro trades at about 23.7× earnings in year five. Cash reconciliation · Risk sensitivity · Market case
Investment Thesis
Metro’s pharmacy business expanded as the Laval produce disruption hurt food sales. A recovery in store traffic can lift earnings, but permanent store investment and rent limit how much of that recovery reaches a share. Metro food and pharmacy sales, p. 22 · Highlighted row · Metro strike estimate and margin, p. 4
Market Mispricing
The market close is just 3.5% above our estimated fair value. The main reason to wait is the five-year upside required relative to XIC. Empirical risk estimates challenge the retained discount rate, so conviction in the wait call is limited.
Recent Developments
The six-month Laval labour conflict ended September 24. Management reports normal service levels and aims to restore traffic. Q4 food same-store sales fell 1.9%, while pharmacy comparable sales grew 5.5%. Metro operating update, p. 2
Earnings Outlook
First-year FCFF is C$886.96m and year-five FCFF C$1,027.20m. Base year one recovers one-quarter of estimated lost pretax strike profit. The adjustment is a level, not a fresh annual gain. Metro strike estimate and margin, p. 4
Valuation Summary
Ten years of cash flow plus a funded terminal period give C$94.27 per share. The prior report’s C$99.18 was a one-year forward valuation. The newly calculated C$81.67 is a maximum purchase price. Preceding November 18 structured edition
Recommended Action and Entry Price
At C$97.58, the model implies 5.67% annual shareholder return versus a 7.5% XIC assumption. At C$81.67, the same dividends and exit value meet a 9.5% annual hurdle after illustrative trading costs.
Catalysts
Q1 food traffic and comparable sales are the first recovery tests. Watch shrink, network investment, and capital spending as well as the headline EPS rebound. Metro operating update, p. 2
Primary Risks to Thesis
The largest risk to waiting is that the market reasonably discounts defensive cash flows below our 6.5% rate. Higher pharmacy growth and faster conversion savings could widen the gap further. Metro food and pharmacy sales, p. 22 · Highlighted row
Company Overview
Metro Inc. is a Canadian company headquartered at 11011 Maurice-Duplessis Boulevard in Montreal, Quebec, with shares listed on the Toronto Stock Exchange under MRU. METRO has a history dating back to 1947 and is a leader in the food and pharmacy industry in Quebec and Ontario. With annual sales of more than $22 billion, the company operates as a retailer, franchisor, manufacturer and distributor. As of September 27, 2025, METRO, its franchisees and affiliated retailers operated 1,006 food stores and 638 pharmacies, including Metro, Metro Plus, Super C, Food Basics, Adonis, Premiere Moisson, PJC Jean Coutu, PJC Sante, PJC Sante Beaute, Brunet, Brunet Plus, Brunet Clinique, Clini Plus, Metro Pharmacy and Food Basics Pharmacy. Annual information form
Products and Services
METRO offers food, pharmacy, health and beauty, over-the-counter medication, general merchandise, ready-to-eat meals, bakery, pastry, deli products, private brand products, generic drugs, pharmacy services and e-commerce services. Its private brands include Irresistible, Selection, Life Smart, Personnelle, Lucky Koi, Harvest Best, Premiere Moisson, Adonis, Phoenicia, Cedar, PJC Jean Coutu, PJC Delices and Pro Doc. The food network includes conventional supermarkets, discount stores, Mediterranean and Middle Eastern specialty stores, neighbourhood stores and artisan bakery and deli stores. The pharmacy network includes franchised PJC and Brunet stores, corporate and franchise Ontario pharmacies, expanded pharmacist consultations, prescription pickup lockers and online pharmacist appointment functionality. Annual information form
Business Model
METRO operates a food and pharmacy retail, franchising, distribution and manufacturing model in Canada. The company earns sales from corporate and consolidated food stores and pharmacies, sales of products supplied to affiliated and franchised food retailers, sales of products supplied to franchised pharmacies, generic drug distribution, private brand products, and services provided to retailers and franchisees. Its operating model combines owned stores, franchised and affiliated retailers, pharmacist-owner networks, distribution centres, food preparation plants, private brands, loyalty programs, e-commerce, and banner support services such as merchandising, marketing, retail accounting, store layouts, insurance programs and advisory services. Metro food and pharmacy sales, p. 22 · Highlighted row
Revenue Drivers
Revenue is driven by food and pharmacy sales volumes, food basket inflation, same-store sales, new store openings, banner conversions, store renovations, pharmacy prescription and front-store activity, product assortment and private brand growth, customer loyalty and personalization, online food sales, delivery and pickup services, sales to affiliated and franchised retailers, royalties based on franchised drugstore sales, sales of products supplied to pharmacy owners, services rendered to franchisees and affiliated retailers, and generic drug distribution through Pro Doc. Fiscal 2026 sales rose 2.5% to CAD 22.55 billion. Fourth-quarter sales rose 1.4% to CAD 5.18 billion. New stores supported revenue while the Laval produce distribution labour disruption weighed on the Quebec food network. Metro food and pharmacy sales, p. 22 · Highlighted row
Cost Structure
METRO's cost structure is driven by retail merchandise procurement, pharmacy distribution, food preparation, warehousing, transportation, labour, rent and occupancy, technology, e-commerce, store and pharmacy renovation, depreciation and amortization, financial costs, advertising, loyalty rewards, private brand development, compliance and inventory shrink. The company operates food warehouses for grocery, general merchandise, non-perishable goods, dairy, meat, frozen foods and produce, two distribution centres serving PJC drugstores, and food preparation operations. Metro sold its commercial bakery production activities in Baie-D’Urfé during Q4 FY2026. Q4 FY2026 gross margin was 19.2%, operating expenses were 10.7% of sales and net financial costs were CAD 39.3 million. Metro income statement, p. 17
Operating Levers
Key operating levers include same-store food sales, same-store pharmacy sales, online food sales, prescription and front-store pharmacy sales, new store openings, banner conversions, store and pharmacy renovations, private brand penetration and product innovation, loyalty membership and customer personalization, e-commerce pickup and delivery capacity, supply chain efficiency, product availability, food basket inflation, gross margin, operating expenses as a percentage of sales, shrink, distribution centre productivity and labour stability. In Q4 FY2026, food same-store sales fell 1.9%, pharmacy same-store sales rose 5.5% and online food sales rose 3.3%. Four discount stores opened in the quarter, including one conversion. Metro operating update, p. 2
Distribution
METRO reaches customers through a segmented banner network of conventional supermarkets, discount stores, neighbourhood grocery stores, specialty food stores and pharmacies. Its food banners include Metro, Metro Plus, Super C, Food Basics, Adonis, Marche Richelieu, Marche Ami and Premiere Moisson, while its pharmacy banners include PJC Jean Coutu, PJC Sante, PJC Sante Beaute, Brunet, Brunet Plus, Brunet Clinique, Clini Plus, Metro Pharmacy and Food Basics Pharmacy. The company supplies corporate, franchised and affiliated stores from owned and affiliated distribution centres, provides services and commercial programs to retailers and franchisees, and extends its customer reach through the Moi loyalty program, mobile applications, personalized communications, click-and-collect, delivery partnerships with DoorDash, Instacart and Uber, smart prescription lockers and online pharmacist appointment tools. Annual information form
Geographic Exposure
METRO's activities are concentrated in Quebec, Ontario and New Brunswick. In food retail, its stores operate in Quebec, Ontario and New Brunswick across conventional, discount, neighbourhood and specialty formats. In pharmacy retail, Jean Coutu and Brunet networks operate primarily in Quebec, with additional PJC drugstores in Ontario and New Brunswick, while Metro Pharmacy and Food Basics Pharmacy operate in Ontario. The company also sells Pro Doc generic drugs mostly in Quebec through the Jean Coutu Group and McMahon. Its operational footprint includes distribution centres and food preparation assets in Quebec and Ontario, including automated fresh and frozen distribution investments in Terrebonne, Laval and Toronto. Annual information form
Regulatory Environment
METRO operates in competitive food and pharmacy markets where intensifying competition, potential new competitors, cost inflation and changing consumer needs can pressure retail prices, margins and operating costs. Its operating activities require government permits and licences, including for alcoholic beverages, tobacco, lottery tickets, pharmaceutical products and medical devices. Certain food and health products are subject to price regulation, including prescription drugs, milk, beer and wine. Food safety and pharmaceutical safety are important operating requirements: suppliers, distribution centres and stores must comply with applicable standards and regulations, including oversight by authorities such as the Canadian Food Inspection Agency, MAPAQ, Health Canada and professional pharmacy standards. The company also monitors climate, supply chain, labour, human rights and responsible procurement obligations, including requirements under the Fighting Against Forced Labour and Child Labour in Supply Chains Act. Annual information form
Industry Structure
Metro is a Canadian food and pharmacy retailer, franchisor, distributor, and manufacturer focused mainly on Quebec, Ontario, and New Brunswick. The 2025 AIF says Metro has a history going back to 1947 and is a leader in the food and pharmacy retailing industry with more than 1,600 retail outlets in Canada and annual sales of more than $22 billion. As of September 27, 2025, Metro, its franchisees, and affiliated retailers operated 1,006 food stores and 638 pharmacies. The food network includes Metro, Metro Plus, Super C, Food Basics, Adonis, Marche Richelieu, Marche Ami, Les 5 Saisons, and Premiere Moisson formats across supermarkets, discount stores, neighborhood stores, and specialty stores. The pharmacy network includes PJC Jean Coutu, PJC Sante, PJC Sante Beaute, Brunet, Brunet Plus, Brunet Clinique, Clini Plus, Metro Pharmacy, and Food Basics Pharmacy. Metro's activities include food retailing and distribution, pharmacy franchising and wholesaling, drug distribution through Pro Doc, food manufacturing and preparation, private brands, loyalty, e-commerce, and support services for affiliated retailers, franchisees, and pharmacist-owners. Annual information form
Growth and Cyclicality
Metro's industry is built around recurring food and pharmacy demand, but growth and margins still move with consumer budgets, inflation, trade conditions, prescription volumes, store investment, and digital adoption. The AIF states that, other than holiday periods that correlate with higher sales, Metro does not have significant seasonality. The annual report states that fiscal 2025 sales were $22.0067 billion, up 3.7%, driven by higher sales in the discount and pharmacy retail networks; food same-store sales increased 2.4%, online food sales increased 18.5%, and pharmacy same-store sales increased 5.6%, including a 6.7% increase in prescription drugs. Management also described high food CPI, pressure on household budgets, rising unemployment, and a strong consumer search for value. StatCan's March 2026 retail release showed Canadian retail sales up 2.1% in the first quarter of 2026, with volume sales up 1.2%, while March core retail sales edged down 0.1%. The same release showed food and beverage retailers up 0.5% in March, with supermarkets and other grocery retailers excluding convenience retailers up 0.8%, indicating that grocery can grow even when broader core retail is softer. Metro operating update, p. 2
Competitors
Metro operates in a highly competitive Canadian food and pharmacy retail market where consumer value, location, assortment, service, pricing, digital convenience, and banner format all matter. The AIF identifies intensifying competition, possible new competitors, higher-than-normal cost inflation, and changing consumer needs as continuing concerns. It also states that increased competition could pressure retail prices and margins, while higher cost inflation could pressure retail prices, margins, and operating costs. Metro responds through store investments, merchandising programs, private label offerings, supply-chain work with partners, and market segmentation across conventional Metro supermarkets, Super C and Food Basics discount banners, Adonis Mediterranean stores, Premiere Moisson specialty stores, and a pharmacy network under Jean Coutu, Brunet, Metro Pharmacy, and Food Basics Pharmacy. The annual report describes a 2025 environment marked by international trade tensions, rising costs for some products, rising unemployment, high food CPI, and stronger consumer search for value. StatCan's March 2026 retail release showed Canadian retail sales up 0.9% month over month, core retail down 0.1%, and food and beverage retailers up 0.5%, led by a 0.8% increase at supermarkets and other grocery retailers excluding convenience retailers. Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Market Share
Metro positions itself as a leader in Quebec and Ontario food and pharmacy retailing through a dense multi-format network and integrated pharmacy presence. The AIF states that Metro is a leader in the food and pharmacy industry in Quebec and Ontario, and the annual report company profile repeats that Metro is a food and pharmacy leader in those provinces. As of September 27, 2025, the network included 710 food stores in Quebec, 289 in Ontario, and 7 in New Brunswick, plus 526 pharmacies in Quebec, 85 in Ontario, and 27 in New Brunswick. The AIF says the Jean Coutu Group is the largest pharmacy chain in Quebec and that its PJC network included 419 drugstores across Quebec, Ontario, and New Brunswick, while Brunet added 141 drugstores. Metro's 2025 operational actions reinforced this positioning through five new Food Basics stores in Ontario, seven new Super C stores in Quebec including five conversions from Metro stores, one Metro store, one Adonis store, two Jean Coutu pharmacies, one Metro Pharmacy, and major renovations or expansions across food and pharmacy locations. The annual report also notes that Metro uses key performance indicators including number of stores, store square footage growth, customer satisfaction, and market share. Annual information form
Competitive Advantages
Metro's source-supported advantages are scale in Quebec and Ontario, multi-banner segmentation, pharmacy franchising and distribution, private brands, loyalty, e-commerce capability, and supply chain infrastructure. The AIF describes Metro as a leader in the food and pharmacy industry in Quebec and Ontario, with more than $22 billion of annual sales, 1,006 food stores, and 638 pharmacies. Its banners address conventional grocery, discount grocery, Mediterranean food, bakery and prepared foods, neighborhood formats, and large, medium, and small pharmacies. Metro's private brand portfolio includes premium, value, health-oriented, health and beauty, over-the-counter, cosmetics, baby, ethnic, bakery, and generic drug offerings, with more than 350 new grocery private brand products and 290 new pharmacy private brand products launched in 2025. The Moi loyalty program reached almost five million customers across Quebec, Ontario, and New Brunswick, supporting personalized promotions across food and pharmacy banners. The annual report adds that Metro invested in discount store openings, pharmacy renovations, delivery, pickup, smart lockers, pharmacist services, and supply chain efficiency, while reporting 2025 gross margin improvement partly from food distribution productivity and store shrink improvement. Metro food and pharmacy sales, p. 22 · Highlighted row
Pricing and Cost Position
Metro's pricing and cost position is shaped by intense competition, food inflation, supplier costs, private labels, store productivity, distribution efficiency, shrink, and pharmacy reimbursement dynamics. The AIF says increased competition could pressure retail prices and margins, while higher-than-normal cost inflation could pressure retail prices, margins, and operating costs. It also states that Metro uses merchandising programs, a strong private label offer, and work with supply chain partners to mitigate cost inflation impacts. The annual report describes 2025 pressure from international trade tensions, shortages, increased production costs, high food CPI, and household budget pressure, with meat, coffee, and fresh vegetables among categories affected. At the same time, the annual report reports fiscal 2025 gross margin of 19.9% compared with 19.7% in fiscal 2024, with improvement partly attributable to food distribution centre productivity gains and shrink improvement in stores. Metro also uses discount banners, conventional banners, specialty banners, private labels, and Moi loyalty promotions to address value-seeking customers. In pharmacy, regulated prescription drugs and professional services create a distinct pricing environment, while the AIF notes prescription drugs are among the products subject to price regulation. Metro strike estimate and margin, p. 4
Entry Barriers and Substitutes
Metro's industry has meaningful operating barriers from store networks, banner rights, real estate, distribution infrastructure, food safety controls, pharmacy regulation, private brand development, loyalty data, franchise services, and supplier relationships. The AIF states that Metro operates or services 1,006 food stores and 638 pharmacies, that its food retail network is supplied by owned warehouses and food preparation plants, and that PJC and Brunet pharmacy franchisees are supported by centralized purchasing, marketing, training, human resources, operational consulting, information systems, and private label programs. Metro also grants banner operating rights at its discretion and requires retailers to meet criteria before using its banners. Substitutes and competitive alternatives remain broad: consumers can shop conventional supermarkets, discount grocery stores, Mediterranean and specialty formats, neighborhood stores, pharmacy banners, mass merchants, digital grocery options, delivery marketplaces, and other health and beauty channels. Metro's own segmentation across Metro, Super C, Food Basics, Adonis, Premiere Moisson, Jean Coutu, Brunet, Metro Pharmacy, and Food Basics Pharmacy reflects that customers can shift among formats when value, convenience, product mix, or service expectations change. Annual information form
Supplier and Customer Dynamics
Metro sits between a broad supplier base and consumers, affiliated retailers, franchisees, and pharmacist-owners. The AIF states that Metro continuously evaluates its supply chain, including distribution methods, facilities, technologies, transportation modes, and supplier relationships, to maintain a cost-efficient supply system. It also states that Metro is not dependent on a single supplier or a small number of suppliers, holds sufficient inventories to support product availability, maintains relationships with many national and regional suppliers, and can turn to another supplier reasonably quickly if a supplier service breakdown occurs. Food stores are supplied by owned warehouses for grocery products, general merchandise, non-perishables, dairy, meat, frozen foods, produce, and neighborhood grocery products; Adonis and Premiere Moisson use additional distribution centres and food preparation plants; PJC and Brunet pharmacies are supported by Jean Coutu Group and McMahon wholesaling and distribution. Customers include grocery shoppers, loyalty members, online grocery users, pharmacy patients, and consumers seeking health, beauty, over-the-counter, cosmetic, baby, prepared-food, bakery, discount, conventional, and specialty offerings. The Moi program reached almost five million customers, and Metro expanded one-hour delivery, Click & Collect, Instacart, pharmacy marketplace delivery, pharmacist appointments, and prescription pickup lockers. Metro balance sheet, p. 19 · Highlighted row
Regulation and Structural Risks
Metro's industry is structurally regulated and operationally exposed to food safety, pharmacy oversight, product pricing rules, labor relations, supply chain disruption, technology, cybersecurity, climate, and evolving corporate responsibility expectations. The AIF states that Metro requires government permits and licences for activities including alcohol, tobacco, lottery tickets, pharmaceutical product distribution, and medical devices, and that some food and health products are subject to price regulation, including prescription drugs, milk, beer, and wine. The annual report says food and pharmaceutical safety risks include contamination, improper handling, defective or improperly labelled products, manufacturing, packaging, labelling, in-store preparation, warehousing, and distribution. It also states that food suppliers must meet applicable regulatory oversight, distribution centres and stores have food safety programs, and pharmacy distribution is subject to Health Canada oversight while pharmacists must meet professional standards. Other risks include prescription drug sales regulation, changing laws and accounting standards, potential work stoppages among unionized store and distribution employees, supplier service breakdowns, distribution-centre interruption, cyberattacks, confidential customer and pharmacy data, climate risks affecting operations and suppliers, and higher fuel, energy, and utility costs. Annual information form
Historical Performance
Fiscal 2026 and 2025 each contained 52 weeks. Sales increased 2.5%, from C$22.01bn to C$22.55bn, but selling disruption and pressure on gross margin reduced parent net income by 13%. Metro income statement, p. 17
Income Statement Analysis
FY2026 sales were C$22,548.7 million, up from C$22,006.7 million. Food sales were C$17,399.1 million and pharmacy sales C$5,149.6 million. Fourth-quarter food comparable sales fell 1.9%, while pharmacy comparable sales rose 5.5%. Adjusted net earnings were C$949.6 million and adjusted diluted EPS C$4.48, down 6.1%. The company estimates the Laval strike reduced full-year net earnings by C$97 million and EPS by C$0.48; that disruption remains within its adjusted earnings measure. Metro income statement, p. 17
Balance Sheet Analysis
At September 26, 2026, cash was C$110.1 million. Current and long-term funded debt totaled C$3,186.7 million, separate from C$1,787.9 million of recognized lease liabilities. Finance-sublease receivables totaled C$469.2 million. These are reporting-date balances, rather than a November cash or debt update. The unused C$600 million revolving facility provides contractual liquidity subject to its terms; it is not cash or unencumbered funding. Metro balance sheet, p. 19 · Highlighted row
Cash Flow Analysis
FY2026 operating cash flow of C$1,561.4 million includes C$130.1 million of working-capital use and C$361.6 million of income taxes paid. Fixed and intangible capital spending totaled C$456.6 million. Deducting that spending, C$134.9 million of funded-debt interest, C$285.4 million of lease principal and C$56.2 million of lease interest, then adding C$99.9 million of finance-sublease principal receipts and C$13.8 million of interest receipts, leaves C$742.0 million before other investments, borrowing and common shareholder returns. This analyst cash bridge differs from the C$819.4 million subtotal that deducts capital spending and lease principal alone; it is not a company-defined free-cash-flow measure. Metro cash-flow statement, p. 21 · Highlighted row
Earnings Quality
GAAP diluted EPS was C$4.18 and adjusted EPS C$4.48. Management did not exclude the strike from adjusted earnings. Restoring all C$97m of estimated lost after-tax profit would assume the sales and margins return. Metro strike estimate and margin, p. 4
Nonrecurring Items
Restructuring, impairment and asset-disposal gains complicate the FY2026 trend. Commercial-bakery and other property proceeds are separate investing receipts and should not be extrapolated as recurring operating cash. The prior audited lease notes distinguish recognized lease principal and interest from variable and short-term rent already expensed in operations. Any continuing-business cash analysis should fund renewed leases and replacement investment, rather than assume expiring contract schedules make occupancy free. Metro strike estimate and margin, p. 4
Funding and Cash Conversion
| Cash bridge | C$ million |
|---|---|
| FY2026 operating cash | 1,561.40 |
| Net lease cash | -227.90 |
| Capital purchases | -456.60 |
| Funded cash interest | -134.90 |
| Historical common cash subtotal | 742.00 |
| Add back funded cash interest | 134.90 |
| Remove share compensation addback | -14.30 |
| Normalize pension timing | -44.10 |
| Cash EBITDA change incl recovery | 92.68 |
| Net rent change | -7.62 |
| Tax: actual paid to modeled cash tax | -11.07 |
| Capex change | -104.66 |
| Working capital change | 101.41 |
| Minority cash | -2.27 |
| Year-one FCFF | 886.96 |
| Unexplained residual | 0.00 |
The two endpoints have different financing bases. The funded-interest add-back converts historical common cash to a pre-financing basis, and the cash-tax row already reconciles actual paid taxes to unlevered modeled taxes. The largest opposing changes are C$104.66m of extra capex and C$101.41m less working-capital use. The latter depends on selected operating balances normalizing; it is a forecast, not recovered cash. Metro cash-flow statement, p. 21 · Highlighted row
Key Ratios
Adjusted diluted EPS was C$4.48 versus GAAP diluted EPS of C$4.18. Operating profit was C$1,342.0 million. Adding depreciation and amortization, restructuring and impairment, then removing disposal gains, gives C$1,994.7 million of recurring operating profit before recognized lease cash, an analyst subtotal equal to about 8.85% of sales. It retains compensation expense. Food and pharmacy revenue are disclosed separately, but separate profit margins are not; assigning segment margins would require estimates. Metro income statement, p. 17
Forward Outlook
Year one assumes food sales grow 3% and pharmacy 4.5%. Continued negative food comps alongside pharmacy growth would weaken the recovery thesis even if reported consolidated sales rose. Metro food and pharmacy sales, p. 22 · Highlighted row · Metro operating update, p. 2
Model Choice
The retained retail FCFF calculator subtracts rent net of sublease receipts, taxes, reinvestment and minority cash before funded-debt interest. Its ten future annual periods run from the valuation date. Receivables from subleases and lease liabilities receive no second adjustment. Metro balance sheet, p. 19 · Highlighted row · Metro cash-flow statement, p. 21 · Highlighted row
Growth
FY2026 food sales of C$17.40bn and pharmacy sales of C$5.15bn become C$17.92bn and C$5.38bn in year one. The issuer does not report separate margins for those two sales streams. Forecast category growth separately and apply a consolidated cash margin. Metro food and pharmacy sales, p. 22 · Highlighted row
Profitability
Reported recurring pre-lease cash operating profit was C$1,994.7m. The base forecast grows that to C$2,087.4m, including C$33.0m of recovered strike earnings. A lasting 50 bp operating-margin improvement raises entry to C$89.98 and still falls short of the close. Metro strike estimate and margin, p. 4
Reinvestment or Required Capital
The base charges C$372.84m maintenance capex and C$188.43m growth capex in year one. Versus reported total purchases of C$456.6m, forecast store/network spending rises. The maintenance/growth split is a model assumption; the issuer’s cash-flow statement reports total purchases. Metro cash-flow statement, p. 21 · Highlighted row
Discount Rate
| Weeks | Beta to XIC | Implied WACC |
|---|---|---|
| 52 | 0.367 | 5.34% |
| 156 | 0.294 | 5.03% |
| 259 | 0.359 | 5.31% |
Base WACC is the preceding verified analyst judgment of 6.5%. The alternatives use CAD adjusted weekly returns for MRU and XIC, last full week before cutoff, a 3.80% government yield, assumed 5% equity premium and 4.75% debt cost before 26.5% tax. Funded-debt weight is measured against November 18 equity value. All empirical cases favor buying. Labour and refinancing uncertainty support a stress premium, but there is limited evidence for the precise 6.5%; we retain that rate to isolate the test of entry discipline. Canada ten-year yield, November 18 · Weekly return inputs
Terminal Economics
Terminal growth is 2.0% nominal and the model funds incremental fixed assets and working capital. Terminal FCFF is C$1,284.2m; its discounted value is 66.9% of operating enterprise value. Results therefore depend on both discount rate and capital productivity.
Bridge to One Common Share
| Year end | Food | Pharmacy | Sales | Cash EBITDA | Rent | Sublease receipts | Tax | Maintenance capex | Growth capex | WC use | Minority | FCFF | DF | PV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-11-18 | 17,921.1 | 5,381.3 | 23,302.4 | 2,087.4 | 353.0 | 117.5 | 372.7 | 372.8 | 188.4 | 28.7 | 2.3 | 887.0 | 0.9390 | 832.9 |
| 2028-11-18 | 18,458.7 | 5,623.5 | 24,082.2 | 2,191.9 | 364.8 | 121.4 | 398.5 | 385.3 | 194.9 | 29.7 | 2.3 | 937.7 | 0.8816 | 826.7 |
| 2029-11-18 | 19,012.5 | 5,876.5 | 24,889.0 | 2,298.5 | 377.1 | 125.5 | 425.3 | 398.2 | 201.7 | 30.7 | 2.4 | 988.6 | 0.8278 | 818.4 |
| 2030-11-18 | 19,582.8 | 6,141.0 | 25,723.8 | 2,363.9 | 389.7 | 129.7 | 441.7 | 411.6 | 208.7 | 31.8 | 2.5 | 1,007.7 | 0.7773 | 783.3 |
| 2031-11-18 | 20,170.3 | 6,417.3 | 26,587.7 | 2,431.4 | 402.8 | 134.1 | 458.7 | 425.4 | 216.0 | 32.9 | 2.6 | 1,027.2 | 0.7299 | 749.8 |
| 2032-11-18 | 20,735.1 | 6,674.0 | 27,409.1 | 2,502.9 | 415.2 | 138.2 | 477.3 | 438.5 | 205.4 | 31.3 | 2.7 | 1,070.8 | 0.6853 | 733.8 |
| 2033-11-18 | 21,274.2 | 6,907.6 | 28,181.8 | 2,570.1 | 426.9 | 142.1 | 489.8 | 450.9 | 193.2 | 29.4 | 2.7 | 1,119.2 | 0.6435 | 720.2 |
| 2034-11-18 | 21,784.8 | 7,114.9 | 28,899.6 | 2,632.6 | 437.8 | 145.7 | 501.5 | 462.4 | 179.5 | 27.3 | 2.8 | 1,167.0 | 0.6042 | 705.1 |
| 2035-11-18 | 22,264.1 | 7,292.7 | 29,556.8 | 2,689.7 | 447.8 | 149.0 | 512.2 | 472.9 | 164.3 | 25.0 | 2.9 | 1,213.7 | 0.5674 | 688.6 |
| 2036-11-18 | 22,709.3 | 7,438.6 | 30,147.9 | 2,741.1 | 456.7 | 152.0 | 521.8 | 482.4 | 147.8 | 22.5 | 2.9 | 1,259.0 | 0.5327 | 670.6 |
| Value bridge | C$ million unless indicated |
|---|---|
| PV 10 years | 7,529.29 |
| PV terminal | 15,201.17 |
| Operating enterprise value | 22,730.46 |
| Cash | 110.10 |
| Debt | -3,186.70 |
| Common equity | 19,653.86 |
| Diluted shares, millions | 208.48 |
| Value / share | 94.27 |
C$3,186.7m of funded debt is deducted once and C$110.1m cash is added. The denominator of 208.48m includes estimated option and PSU dilution. Model cash flows already deduct minority cash. Metro balance sheet, p. 19 · Highlighted row · Metro share capital and awards, p. 25
Price-Implied Expectations
At unchanged calibrated growth, only about 17 bp of permanent additional pre-lease margin is needed to raise fair value from C$94.27 to C$97.58. The harder question is whether that price delivers the portfolio hurdle. The distinct five-year exit test is in Scenarios.
Independent Cross-Check
Q4 food comps were negative; prescribing an immediate complete operating recovery would be aggressive. Conversely, the close is 23.3× FY2026 reported diluted EPS or 21.8× adjusted EPS. Reported earnings were depressed by the strike. In the five-year cross-check, the multiple depends directly on how quickly customers return. Metro operating update, p. 2 · Metro income statement, p. 17
Conclusion and Change from Prior Edition
Fair value matches the preceding published C$94.27 to the cent. The entry is new. A C$99.18 forward price assumes a year of business activity and retained cash and cannot serve as the price paid today. Preceding November 18 structured edition
Peer Selection
Metro and Loblaw both sell groceries and pharmacy products. Empire provides a food-led comparison. We use each company’s latest financial statements publicly available at the November 18 close. Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Dated Ratio Table
| Latest quarter available Nov 18, 2026 | Sales C$m | Operating margin | Parent net margin |
|---|---|---|---|
| Metro, 12 weeks to Sep 26 | 5,179.5 | 5.96% | 3.88% |
| Loblaw, 12 weeks to Jun 20 | 15,046.0 | 7.99% | 4.99% |
| Empire, 13 weeks to Aug 1 | 8,475.0 | 4.85% | 2.75% |
Ratios are reported operating profit divided by revenue, and parent net income divided by revenue. Metro EBIT includes the bakery disposal and impairments; the comparable quarter differs in both season and duration. Metro income statement, p. 17 · Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Comparability Adjustments
Loblaw’s November 19 results fall after the cutoff. We use its June quarter and Empire’s August quarter. Empire includes certain equity income in operating income. A spread between reported margins cannot all be attributed to superior retail execution. Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Implications for Value
Metro’s reported margin sits between the two peers. Better throughput can narrow the gap with Loblaw; a flat sales recovery could instead leave Metro with much the same fixed distribution costs on fewer cases shipped. Metro strike estimate and margin, p. 4 · Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Bear Case
Bear fair value is C$47.83 with an 8% WACC and weaker operating recovery. That represents roughly 41% downside even at the base entry. The forecast pays dividends only within modeled funding capacity.
Base Case
Base fair value of C$94.27 implies 3.4% downside at the close and 15.4% upside at entry. The modeled five-year return at the close includes retained cash and ordinary cash dividends.
Bull Case
Bull fair value is C$180.79. It combines a 5.2% WACC with stronger operating assumptions. The wide range illustrates the leverage of perpetual cash flows to the discount rate; scenario values carry no assigned probabilities.
Outcomes at Close and Entry
| Assumption | Close | Fair value | Maximum entry | Price rule |
|---|---|---|---|---|
| Base | $97.58 | $94.27 | $81.67 | Wait |
| Margin down 50 bp | $97.58 | $84.48 | $73.35 | Wait |
| Margin up 50 bp | $97.58 | $104.07 | $89.98 | Wait |
| 52-week risk | $97.58 | $132.99 | $108.85 | Buy |
| 156-week risk | $97.58 | $148.61 | $119.80 | Buy |
| 156-week risk and margin up 50 bp | $97.58 | $163.20 | $131.48 | Buy |
| 259-week risk | $97.58 | $134.47 | $109.88 | Buy |
| Bear | $97.58 | $47.83 | $44.54 | Wait |
| Bull | $97.58 | $180.79 | $147.55 | Buy |
The combined 156-week discount calibration and 50 bp higher margin gives a C$131.48 entry. The same margin change alone yields C$89.98. Prices are CAD per share. Buy/Wait compares the close with the entry before portfolio sizing.
Market-Implied Case
| Assumed EPS growth | Year-five diluted EPS | Exit P/E needed at close |
|---|---|---|
| 4% | 5.09 | 28.6× |
| 6% | 5.59 | 26.0× |
| 8% | 6.14 | 23.7× |
At C$97.58, the 9.5% hurdle requires a C$145.26 year-five exit with C$8.65 cumulative dividends and 10 bp on entry and exit. EPS starts at FY2026 C$4.18. At 8% EPS growth the required 23.7× is near the starting 23.3×. Falling market share, persistent negative comparable food sales or a lower exit multiple would undermine this case. Metro income statement, p. 17
Analyst Assessment
The base year-five exit is C$120.16. Lower historical risk rates create enough upside to change the call without assuming a stronger food recovery. Reviewers should challenge the discount premium first; next challenge working-capital normalization.
Operating Risks
METRO's operating risk is concentrated in food and pharmacy retail across Quebec, Ontario and New Brunswick. The 2025 Annual Information Form describes 1,006 food stores and 638 pharmacies, supported by franchising, wholesale distribution, manufacturing, private brands and loyalty operations. This scale creates exposure to store execution, affiliated merchants, pharmacist-owners, warehouses, distribution centres, manufacturing sites, inventory control, product quality and supplier service levels. The 2025 Annual Report states that product contamination, improper handling, defective or improperly labelled products, recalls and public-health concerns can create liabilities, costs and reputational damage, especially because food products represent the highest proportion of sales. Pharmacy activities add regulatory and professional-standard risk through prescription products, Health Canada oversight and pharmacist-owner operations. Technology is another operating dependency: METRO says virtually all aspects of its business depend on information systems, while online shopping, pharmacy data and the Moi loyalty program increase cyber and privacy exposure. Recent events show the operating sensitivity of the network: the Toronto frozen products distribution centre shutdown caused inventory losses and other direct costs, and the Laval produce distribution labour disruption ended September 24, 2026 after roughly six months. Metro reported restored service levels, while food same-store sales remained negative in the first four weeks of FY2027. Metro operating update, p. 2
Financial and Liquidity Risks
Metro ended FY2026 with CAD 110.1 million of cash and an unused CAD 600 million authorized revolving credit facility. Book debt rose to CAD 3.19 billion and lease liabilities totaled CAD 1.79 billion. Operating cash flow fell to CAD 1.56 billion from CAD 1.72 billion, while buybacks and dividends together used over CAD 1 billion. Lower earnings or working-capital pressure would reduce room for investment and shareholder returns. Interest rates, scheduled refinancing, credit exposure to retailers and foreign-currency purchases remain financial risks. Metro balance sheet, p. 19 · Highlighted row
Regulatory and Legal Risks
METRO's food, pharmacy, franchising, employment, privacy, product-safety, environmental, securities and competition obligations create legal and regulatory risk. The annual report states that laws, accounting standards and regulations governing the business are constantly evolving and that new requirements affecting METRO or its franchisees could materially affect performance and sales growth. Prescription drug sales are specifically exposed because the pharmacy activities and pharmacist-owner franchisees operate in regulated areas. Product safety controls are subject to Canadian Food Inspection Agency, MAPAQ, Health Canada and other oversight depending on the activity and jurisdiction. Cybersecurity and data protection carry additional compliance risk because METRO collects confidential information from customers, suppliers, employees, partners, loyalty participants and pharmacy customers. The annual report and AIF disclose ordinary-course proceedings and claims and say litigation outcomes and potential losses are uncertain. Specific disclosed matters include opioid-related class actions involving Pro Doc and Jean Coutu Group, a Canadian Competition Bureau investigation and proposed class actions related to commercial bread, and a Sopropharm proceeding involving Jean Coutu Group franchise agreement provisions. METRO says no provisions for contingent losses were recognized for these matters, but the proceedings remain a risk source until resolved. Annual information form
Industry and Competitive Risks
METRO operates in competitive Canadian food and pharmacy retail markets where pricing, banner mix, value perception, store locations, e-commerce, loyalty, labour availability and supplier relationships can affect sales and margins. The 2025 Annual Report identifies intensifying competition, possible new competitors, higher-than-normal cost inflation and changing consumer needs as constant concerns. It also states that increased competition could pressure retail prices and margins, while elevated cost inflation can pressure retail prices, margins and operating costs. METRO's segmentation across Metro and Metro Plus conventional supermarkets, Super C and Food Basics discount banners, Adonis, Premiere Moisson, Jean Coutu, Brunet and pharmacy banners helps address different customer needs, but it also requires continued merchandising, pricing and store investment discipline. Q4 FY2026 food same-store sales fell 1.9%, pharmacy same-store sales rose 5.5% and gross margin fell to 19.2% from 20.0%. The Laval disruption contributed to the food and margin weakness, while new stores supported total sales. Statistics Canada's March 2026 retail release adds industry context: Canadian retail sales increased 0.9%, core retail sales edged down 0.1%, retail sales fell 0.7% in volume terms, Quebec retail sales decreased 0.8%, Ontario retail sales increased 1.4%, and food and beverage retailers increased 0.5%. These mixed indicators show that industry demand can shift by geography, subsector and real volume. Loblaw Q2 income statement, p. 46 · Empire Q1 income statement, p. 27
Thesis-Specific Risks and Reconsideration Triggers
The company-specific risk case for METRO centres on execution in discount expansion, pharmacy network growth, supply chain reliability, private-label value, loyalty, e-commerce, technology resilience and corporate responsibility commitments. The annual report says medium- and long-term targets assume continued execution of the business, strategic and capital plans; historical inflation; no material macroeconomic, regulatory, competitive, labour, supply-chain or distribution-centre disruptions; effective merchandising and promotions; and efficient operation of distribution centres and stores. Those assumptions are vulnerable to events already visible in the sources, including the Toronto freezer interruption, the Laval produce distribution centre strike, international trade tensions, product shortages, higher production costs and pressure on household budgets. Metro plans nine more Ontario Metro-to-Food Basics conversions and seven new discount stores in FY2027 as it works to rebuild grocery traffic after the Laval dispute. Its plans for pharmacy and discount growth, renovate and expand pharmacy locations, grow rapid delivery and pickup, use the Moi program for personalized promotions, and continue technology and store investments could underperform if customers shift behavior, competitors respond aggressively, systems fail, cyber threats increase, or pharmacy regulation changes. Corporate responsibility execution is also part of the risk profile: the sustainability report identifies product quality and safety, data security, labour relations, customer satisfaction, responsible procurement, climate change, waste, food loss and employee health and safety as material issues, any of which could affect reputation, operations or financial performance. Metro strike estimate and margin, p. 4
Environmental Factors
METRO reports environmental factors through its 2025 Corporate Responsibility Report, which covers the 2025 fiscal year ended September 27, 2025 and is aligned to SASB Food Retailers & Distributors, SASB Drug Retailers and GRI Standards. Environmental priorities include climate change, waste, food loss and waste, responsible procurement, packaging and printed materials, and supplier practices. METRO reports that Scopes 1 and 2 greenhouse gas emissions received limited assurance from its external auditor and that Scopes 1 and 2 emissions decreased 2.9% versus the 2023 baseline year. The company maintains five near-term GHG reduction objectives while no longer pursuing SBTi validation because of the broader FLAG deforestation scope required by SBTi. Refrigeration is a key focus because refrigerant leaks are the largest contributor to direct GHG emissions; in 2025, METRO completed 54 refrigeration projects, including conversions to lower-GWP gases and refurbishments of aging equipment. Waste controls include store-level and distribution-centre diversion programs, an Environment Ambassador pilot, organics recovery, recycling, food donations, food rescue apps and improved sorting. The report states that the 2025 store diversion rate reached 78.5%, distribution and production centres reached an 89% diversion rate, and METRO reduced the food loss and waste ratio in stores by 27% versus its 2016 baseline. 2025 corporate responsibility report
Social Factors
METRO's social factors include customers, colleagues, health and safety, equity, diversity and inclusion, responsible procurement, human rights, communities and food security. The 2025 Corporate Responsibility Report describes METRO as a food and pharmacy leader in Quebec and Ontario, operating or servicing 1,006 food stores and 638 pharmacies, with more than 97,000 colleagues working directly or indirectly for METRO and more than 53,000 working directly for METRO. The report says ED&I is integrated into human resources processes, including hiring, onboarding, training and recruitment partnerships that reach newcomers, asylum seekers, women from diverse backgrounds, newly arrived workers, people with intellectual disabilities and autistic people. It also reports the Maurice-Pollack Award for ethnocultural diversity management and recognition among Montreal's Top Employers and Canada's Top Employers for Young People. Health and safety priorities include harmonized processes across Quebec and Ontario, ergonomics and injury prevention, incident management, accident investigations, safety interaction programs, Detect & Correct in retail stores, stronger safety training and mental-health training. Community impact includes PRISM certification from Imagine Canada for donating at least 1% of pre-tax profits to local communities, food and money donations to organizations and food banks, the One More Bite program, food rescue apps, shared kitchens, support for health-care access, and community investments intended to reduce inequalities related to food and health. 2025 corporate responsibility report
Governance Factors
METRO's corporate responsibility governance is integrated into management and overseen by the Board of Directors. The 2025 Corporate Responsibility Report states that the Board oversees activities and disclosure related to corporate responsibility, including ESG matters, through the Governance and Corporate Responsibility Committee, and also approves corporate responsibility plans and reports. The Executive Committee approves the corporate responsibility strategy, aligns priorities with business strategy and incentive plans for relevant executives and employees, and monitors objectives. The Vice President, Public Affairs and Communications develops strategic corporate responsibility directives and reports progress to the Executive Committee and the Governance and Corporate Responsibility Committee. In-house teams report to the vice presidents responsible for CR Plan programs, and specific working groups or committees support environment, climate change, equity, diversity and inclusion, responsible procurement, packaging and printed materials, and health and safety. The Annual Information Form repeats this governance structure and says the Board approves corporate responsibility plans and reports. The proxy circular describes 91% independent director nominees, 45% women director nominees, separation of the CEO and Chair roles, annual director elections, a Directors' Code of Ethics, majority voting, annual Board-effectiveness assessment, shareholder engagement, Board oversight of ESG matters and climate risk, and Board oversight of operational risks including cybersecurity. Voting rights and ownership, p. 18
Financially Material Risks and Opportunities
METRO's ESG risks and opportunities are tied to food and pharmacy retail operations, supply chain resilience, climate transition, refrigerant management, waste diversion, food loss and waste, food security, responsible procurement, human rights, data security, health and safety, labour availability, regulatory change and reputation. The 2025 Annual Report says risks that could affect performance include supply chain, distribution centre or technology disruptions, material labour shortages or conflicts, and events that significantly damage brand or reputation. The Annual Information Form incorporates the Annual Report's risk-management section and states that competitive pressures, cost inflation, changing consumer needs and supply-chain efficiency are constant concerns. ESG-specific risk factors include the evolving regulatory landscape for human rights, supplier social and environmental standards, Scopes 1 and 2 climate assurance, food waste reduction, corporate donations, professional inclusion and community investment. The 2025 Corporate Responsibility Report identifies data security, climate change, food waste, waste, equity, diversity and inclusion, packaging and printed materials, responsible procurement and human rights as material topics. Opportunities in the selected sources include stronger supplier assessment through Sphera, continuous improvement plans for suppliers below METRO's compliance threshold, an updated Supplier Code of Conduct, a first Human Rights Statement, food rescue partnerships, community investment, fast-charging infrastructure at store locations, and ESG objectives in executive long-term incentives. 2025 corporate responsibility report
Annual Results
| CAD millions | FY2025 | FY2026 |
|---|---|---|
| Sales | 22,006.7 | 22,548.7 |
| Gross profit | 4,370.3 | 4,370.9 |
| Pretax income | 1,320.2 | 1,177.6 |
| Parent earnings | 1,017.0 | 883.9 |
Fiscal years ended September 2025 and 2026, 52 weeks each. Metro income statement, p. 17
Interim Results
| CAD millions | 2025 Q4 | 2026 Q4 |
|---|---|---|
| Sales | 5,108.7 | 5,179.5 |
| Gross profit | 1,021.8 | 993.8 |
| Pretax income | 286.0 | 269.4 |
| Parent earnings | 216.0 | 200.8 |
Quarterly observations are the final 12 weeks in each fiscal year. Metro income statement, p. 17
Trailing Results
The latest trailing period equals FY2026. Twelve-month sales were C$22,548.7m, pretax profit C$1,177.6m and parent net income C$883.9m. Metro income statement, p. 17
Material Adjustments
Model recurring cash profit reverses C$25.7m restructuring and C$33.9m impairment, then removes C$32.1m disposal gains; these adjustments flow into the cash bridge once. Metro strike estimate and margin, p. 4
Annual Positions
| CAD millions | FY2025 | FY2026 |
|---|---|---|
| Cash | 67.3 | 110.1 |
| Inventory | 1,604.3 | 1,617.6 |
| Total assets | 14,539.4 | 14,731.5 |
| Total equity | 7,045.1 | 6,896.8 |
Reported year ends, September 2025 and 2026. Metro balance sheet, p. 19 · Highlighted row
Interim Positions
| CAD millions | 2026 July 4 | 2026 Sept 26 |
|---|---|---|
| Cash | 49.9 | 110.1 |
| Inventory | 1,599.4 | 1,617.6 |
| Total assets | 14,705.5 | 14,731.5 |
| Total equity | 6,978.5 | 6,896.8 |
July Q3 and September year-end snapshots. Metro balance sheet, p. 19 · Highlighted row · Q3 position, p. 21
Capital and Claims Reconciliation
The September book has C$1,787.9m in lease liabilities including the current portion. Cash rent and sublease receipts enter operating FCFF, so only funded debt reduces common equity. Metro balance sheet, p. 19 · Highlighted row
Annual Flows
| CAD millions | FY2025 | FY2026 |
|---|---|---|
| Operating cash | 1,724.9 | 1,561.4 |
| Fixed and intangible purchases | 510.6 | 456.6 |
| Net recognized lease cash | 223.4 | 227.9 |
| Funded interest paid | 126.5 | 134.9 |
| Dividends paid | 316.8 | 335.7 |
| Shares redeemed | 790.0 | 696.5 |
Purchases and financing payments shown as positive uses. Metro cash-flow statement, p. 21 · Highlighted row
Interim Flows
| CAD millions | 2025 Q4 | 2026 Q4 |
|---|---|---|
| Operating cash | 499.1 | 436.4 |
| Fixed and intangible purchases | 190.0 | 142.1 |
| Net recognized lease cash | 42.1 | 37.8 |
| Funded interest paid | 17.4 | 20.5 |
| Dividends paid | 79.9 | 84.8 |
| Shares redeemed | 277.9 | 164.7 |
Same 12-week fiscal quarters. Quarterly working-capital releases and tax timing prevent simple annualization. Metro cash-flow statement, p. 21 · Highlighted row
Trailing Flows
FY2026 is the latest trailing year. Operating cash fell C$163.5m while capital purchases fell C$54m. Lower capital spending cushioned the decline in cash available to holders. Metro cash-flow statement, p. 21 · Highlighted row
Reconciliation to Common Shareholders
Ordinary dividends consumed C$335.7m and redemptions C$696.5m, versus C$742.0m of common cash after rent, interest and capex. The financing statement also shows net debt issuance; the forecast assumes constant funded debt and does not extrapolate repurchases. Metro cash-flow statement, p. 21 · Highlighted row
Primary Sources and Locators
The source ledger identifies the financial statement rows, market observations and assumption sources. Metro cash-flow statement, p. 21 · Highlighted row · Metro food and pharmacy sales, p. 22 · Highlighted row
Frozen Inputs and Assumptions
All public forecasts and rationales are visible in retail inputs. The retail calculator uses model helpers; the public copy omits private storage identifiers. Market risk uses aligned adjusted weekly closes, in date, MRU, XIC order. TSX daily close, Nov 18
Worksheets and Saved Outputs
| Worksheet | Output |
|---|---|
| Retail valuation and entry | decision · cash-bridge · forecast · risk · market-case |
| Statements and comparisons | income-annual · income-interim · balance-annual · balance-interim · cash-annual · cash-interim · peers |
Run valuation.py then financials.py in support/ using Python 3.12 and the standard library. The 9.5% hurdle combines a 7.5% modeled Canadian index return with a 2-point premium; use cumulative dividends held as cash and 10 bp costs each way. The entry is the lesser of fair value and the hurdle-preserving purchase price, rounded down to cents.
Changes from the Preceding Edition
| Revision driver | Fair value | Maximum entry |
|---|---|---|
| Prior | $94.27 | N/A |
| Retained retail FCFF | 0.00 | N/A |
| Rounding | 0.00 | N/A |
| Current | $94.27 | $81.67 |
The prior maximum entry is unavailable. The old report supplied present fair value and a one-year forward target only. The retained economic cutoff and share basis permit an exact fair-value reconciliation. Preceding November 18 structured edition
Closing prices
| Date | Close (CAD) |
|---|---|
| 2025-11-20 | 100.30 |
| 2025-11-21 | 100.19 |
| 2025-11-24 | 98.34 |
| 2025-11-25 | 100.14 |
| 2025-11-26 | 100.05 |
| 2025-11-27 | 99.95 |
| 2025-11-28 | 100.26 |
| 2025-12-01 | 100.81 |
| 2025-12-02 | 99.71 |
| 2025-12-03 | 98.39 |
| 2025-12-04 | 99.88 |
| 2025-12-05 | 99.85 |
| 2025-12-08 | 99.85 |
| 2025-12-09 | 99.80 |
| 2025-12-10 | 98.63 |
| 2025-12-11 | 98.92 |
| 2025-12-12 | 99.02 |
| 2025-12-15 | 99.02 |
| 2025-12-16 | 99.32 |
| 2025-12-17 | 99.53 |
| 2025-12-18 | 99.76 |
| 2025-12-19 | 97.99 |
| 2025-12-22 | 98.42 |
| 2025-12-23 | 98.48 |
| 2025-12-24 | 97.97 |
| 2025-12-29 | 98.58 |
| 2025-12-30 | 98.64 |
| 2025-12-31 | 98.79 |
| 2026-01-02 | 99.01 |
| 2026-01-05 | 98.68 |
| 2026-01-06 | 98.46 |
| 2026-01-07 | 97.47 |
| 2026-01-08 | 97.95 |
| 2026-01-09 | 98.37 |
| 2026-01-12 | 99.95 |
| 2026-01-13 | 98.72 |
| 2026-01-14 | 98.71 |
| 2026-01-15 | 98.27 |
| 2026-01-16 | 97.57 |
| 2026-01-19 | 98.20 |
| 2026-01-20 | 97.95 |
| 2026-01-21 | 99.08 |
| 2026-01-22 | 99.52 |
| 2026-01-23 | 99.38 |
| 2026-01-26 | 98.32 |
| 2026-01-27 | 92.93 |
| 2026-01-28 | 90.68 |
| 2026-01-29 | 90.41 |
| 2026-01-30 | 90.39 |
| 2026-02-02 | 91.49 |
| 2026-02-03 | 93.11 |
| 2026-02-04 | 95.62 |
| 2026-02-05 | 95.67 |
| 2026-02-06 | 95.75 |
| 2026-02-09 | 95.35 |
| 2026-02-10 | 94.51 |
| 2026-02-11 | 95.21 |
| 2026-02-12 | 96.64 |
| 2026-02-13 | 97.31 |
| 2026-02-17 | 98.21 |
| 2026-02-18 | 98.28 |
| 2026-02-19 | 98.43 |
| 2026-02-20 | 97.13 |
| 2026-02-23 | 99.56 |
| 2026-02-24 | 97.99 |
| 2026-02-25 | 96.60 |
| 2026-02-26 | 96.95 |
| 2026-02-27 | 97.19 |
| 2026-03-02 | 98.00 |
| 2026-03-03 | 96.97 |
| 2026-03-04 | 95.85 |
| 2026-03-05 | 96.13 |
| 2026-03-06 | 95.12 |
| 2026-03-09 | 95.40 |
| 2026-03-10 | 94.72 |
| 2026-03-11 | 93.76 |
| 2026-03-12 | 93.61 |
| 2026-03-13 | 95.02 |
| 2026-03-16 | 96.81 |
| 2026-03-17 | 95.65 |
| 2026-03-18 | 94.82 |
| 2026-03-19 | 93.77 |
| 2026-03-20 | 94.52 |
| 2026-03-23 | 95.69 |
| 2026-03-24 | 94.28 |
| 2026-03-25 | 94.17 |
| 2026-03-26 | 93.54 |
| 2026-03-27 | 94.12 |
| 2026-03-30 | 95.30 |
| 2026-03-31 | 95.18 |
| 2026-04-01 | 95.54 |
| 2026-04-02 | 96.44 |
| 2026-04-06 | 96.88 |
| 2026-04-07 | 96.62 |
| 2026-04-08 | 98.04 |
| 2026-04-09 | 94.15 |
| 2026-04-10 | 92.93 |
| 2026-04-13 | 92.73 |
| 2026-04-14 | 92.35 |
| 2026-04-15 | 92.87 |
| 2026-04-16 | 91.16 |
| 2026-04-17 | 91.43 |
| 2026-04-20 | 92.20 |
| 2026-04-21 | 92.88 |
| 2026-04-22 | 90.35 |
| 2026-04-23 | 89.88 |
| 2026-04-24 | 91.09 |
| 2026-04-27 | 90.85 |
| 2026-04-28 | 90.33 |
| 2026-04-29 | 89.37 |
| 2026-04-30 | 91.06 |
| 2026-05-01 | 91.16 |
| 2026-05-04 | 90.09 |
| 2026-05-05 | 89.55 |
| 2026-05-06 | 88.77 |
| 2026-05-07 | 88.86 |
| 2026-05-08 | 89.32 |
| 2026-05-11 | 88.14 |
| 2026-05-12 | 88.20 |
| 2026-05-13 | 88.07 |
| 2026-05-14 | 88.79 |
| 2026-05-15 | 89.00 |
| 2026-05-19 | 90.06 |
| 2026-05-20 | 90.02 |
| 2026-05-21 | 90.02 |
| 2026-05-22 | 89.34 |
| 2026-05-25 | 89.25 |
| 2026-05-26 | 87.44 |
| 2026-05-27 | 87.95 |
| 2026-05-28 | 88.48 |
| 2026-05-29 | 88.47 |
| 2026-06-01 | 88.49 |
| 2026-06-02 | 87.68 |
| 2026-06-03 | 89.02 |
| 2026-06-04 | 88.76 |
| 2026-06-05 | 92.64 |
| 2026-06-08 | 92.36 |
| 2026-06-09 | 94.16 |
| 2026-06-10 | 93.75 |
| 2026-06-11 | 94.13 |
| 2026-06-12 | 93.21 |
| 2026-06-15 | 92.60 |
| 2026-06-16 | 92.67 |
| 2026-06-17 | 91.88 |
| 2026-06-18 | 91.71 |
| 2026-06-19 | 91.50 |
| 2026-06-22 | 89.80 |
| 2026-06-23 | 91.65 |
| 2026-06-24 | 94.62 |
| 2026-06-25 | 94.21 |
| 2026-06-26 | 92.98 |
| 2026-06-29 | 90.99 |
| 2026-06-30 | 90.68 |
| 2026-07-02 | 90.85 |
| 2026-07-03 | 90.11 |
| 2026-07-06 | 89.46 |
| 2026-07-07 | 90.07 |
| 2026-07-08 | 91.88 |
| 2026-07-09 | 91.56 |
| 2026-07-10 | 93.64 |
| 2026-07-13 | 94.46 |
| 2026-07-14 | 93.56 |
| 2026-07-15 | 93.30 |
| 2026-07-16 | 94.11 |
| 2026-07-17 | 94.02 |
| 2026-07-20 | 92.32 |
| 2026-07-21 | 92.67 |
| 2026-07-22 | 92.29 |
| 2026-07-23 | 91.12 |
| 2026-07-24 | 92.53 |
| 2026-07-27 | 93.44 |
| 2026-07-28 | 94.82 |
| 2026-07-29 | 95.36 |
| 2026-07-30 | 93.71 |
| 2026-07-31 | 93.18 |
| 2026-08-04 | 92.78 |
| 2026-08-05 | 91.64 |
| 2026-08-06 | 90.31 |
| 2026-08-07 | 90.35 |
| 2026-08-10 | 89.81 |
| 2026-08-11 | 89.78 |
| 2026-08-12 | 89.98 |
| 2026-08-13 | 89.49 |
| 2026-08-14 | 88.05 |
| 2026-08-17 | 87.90 |
| 2026-08-18 | 87.61 |
| 2026-08-19 | 89.31 |
| 2026-08-20 | 89.71 |
| 2026-08-21 | 89.40 |
| 2026-08-24 | 90.21 |
| 2026-08-25 | 89.96 |
| 2026-08-26 | 90.21 |
| 2026-08-27 | 89.01 |
| 2026-08-28 | 88.26 |
| 2026-08-31 | 88.02 |
| 2026-09-01 | 88.58 |
| 2026-09-02 | 88.82 |
| 2026-09-03 | 89.69 |
| 2026-09-04 | 90.05 |
| 2026-09-08 | 90.10 |
| 2026-09-09 | 90.15 |
| 2026-09-10 | 88.64 |
| 2026-09-11 | 88.16 |
| 2026-09-14 | 91.55 |
| 2026-09-15 | 89.84 |
| 2026-09-16 | 91.40 |
| 2026-09-17 | 91.80 |
| 2026-09-18 | 91.46 |
| 2026-09-21 | 91.44 |
| 2026-09-22 | 91.62 |
| 2026-09-23 | 90.20 |
| 2026-09-24 | 89.69 |
| 2026-09-25 | 90.60 |
| 2026-09-28 | 90.51 |
| 2026-09-29 | 90.53 |
| 2026-09-30 | 89.95 |
| 2026-10-01 | 89.78 |
| 2026-10-02 | 89.09 |
| 2026-10-05 | 89.65 |
| 2026-10-06 | 88.98 |
| 2026-10-07 | 89.51 |
| 2026-10-08 | 90.72 |
| 2026-10-09 | 90.38 |
| 2026-10-13 | 91.27 |
| 2026-10-14 | 92.83 |
| 2026-10-15 | 95.09 |
| 2026-10-16 | 97.14 |
| 2026-10-19 | 95.68 |
| 2026-10-20 | 96.03 |
| 2026-10-21 | 95.87 |
| 2026-10-22 | 97.93 |
| 2026-10-23 | 96.33 |
| 2026-10-26 | 96.50 |
| 2026-10-27 | 95.34 |
| 2026-10-28 | 94.79 |
| 2026-10-29 | 95.35 |
| 2026-10-30 | 97.04 |
| 2026-11-02 | 98.25 |
| 2026-11-03 | 98.18 |
| 2026-11-04 | 99.96 |
| 2026-11-05 | 99.47 |
| 2026-11-06 | 98.61 |
| 2026-11-09 | 98.20 |
| 2026-11-10 | 98.55 |
| 2026-11-11 | 98.49 |
| 2026-11-12 | 98.59 |
| 2026-11-13 | 99.56 |
| 2026-11-16 | 101.49 |
| 2026-11-17 | 100.92 |
| 2026-11-18 | 97.58 |